HAIC Plus H101 vs HAIC Alone for Unresectable HCC at BCLC A-B
Status:
Recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
Hepatic artery infusion chemotherapy (HAIC) is effective and safe for hepatocellular
carcinoma (HCC). Recombinant Human Type-5 Adenovirus (H101) is safe for HCC. The purpose of
this study is to evaluate the efficacy and safety of HAIC combined with H101 compared with
HAIC alone in patients with unresectable hepatocellular carcinoma (HCC) at barcelona clinic
liver cancer A-B stage.